Results 11 to 20 of about 194,799 (383)
Ventilator associated pneumonia
Journal of Pediatric Critical Care, 2019 Ventilator-associated pneumonia (VAP) is one of the most frequent hospital-acquired infections occurring in intubated patients. Because VAP is associated with higher mortality, morbidity and healthcare costs, there is a need to solicit further research ...
Sham Lohiya +3 more
doaj +6 more sources
Ventilator-associated pneumonia [PDF]
European Respiratory Journal, 2001 To the Editor: The recent task force report is a welcome review of the situation regarding ventilator associated pneumonia (VAP) 1. In the prevention of VAP section …
Mike Tweed
+11 more sources
Prevention of ventilator-associated pneumonia
Revista Portuguesa de Pneumologia, 2014 Invasive mechanical ventilation (IMV) represents a risk factor for the development of ventilator-associated pneumonia (VAP), which develops at least 48 h after admission in patients ventilated through tracheostomy or endotracheal intubation.
J. Oliveira, C. Zagalo, P. Cavaco-Silva
doaj +4 more sources
The Prevention of Ventilator-Associated Pneumonia [PDF]
Survey of Anesthesiology, 1999 Nosocomial pneumonia is a leading cause of death from hospital-acquired infections, with an associated crude mortality rate of approximately 30 percent.1 Ventilator-associated pneumonia refers specifically to nosocomial bacterial pneumonia that has developed in patients who are receiving mechanical ventilation.
S L Katz
openalex +4 more sources
Ventilator associated pneumonia [PDF]
BMJ, 2006 Abstract Hospital acquired or nosocomial infections continue to be an important cause of morbidity and mortality. The critically ill patient is at particular risk of developing intensive care unit acquired infection, with the lungs being especially vulnerable.
Jason R. Leong, David T. Huang
openaire +8 more sources
Ventilator-Associated Pneumonia [PDF]
Archives of Internal Medicine, 2000 Ventilator-associated pneumonia is a common complication in intensive care units, occurring in 9% to 24% of patients intubated for longer than 48 hours. Because of this large disease burden and the resultant attributable morbidity and mortality, there is great interest in accurately diagnosing, treating, and preventing this complication.
Richard S Morehead, Simmy Jerry Pinto
openaire +5 more sources
JAMA Network Open, 2022 This randomized clinical trial compares the clinical response to Gram stain–guided vs guideline-based antibiotic therapy in patients with ventilator-associated pneumonia.
J. Yoshimura +11 more
semanticscholar +1 more source
Ventilator-associated Pneumonia
Seminars in Respiratory and Critical Care Medicine, 2014 Ventilator-associated pneumonia (VAP) is an iatrogenic pulmonary infection that develops in tracheally intubated patients on mechanical ventilation for at least 48 hours. VAP is the nosocomial infection with the greatest impact on patient outcomes and health care costs.
Antoni Torres +4 more
openaire +6 more sources
Journal of Clinical Medicine, 2022 Specific lung ultrasound signs combined with clinical parameters allow for early diagnosis of ventilator-associated pneumonia in the general ICU population. This retrospective cohort study aimed to determine the accuracy of lung ultrasound monitoring for
S. Mongodi +13 more
semanticscholar +1 more source
Ventilator-Associated Pneumonia [PDF]
, 2020 Ventilator-associated pneumonia occurs in patients who have been intubated for at least 2–3 days with significant exposure to hospital-acquired organisms. Treatment should be initiated rapidly and cover Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, and methicillin-resistant Staphylococcus aureus(MRSA).
Jennifer P. Stevens +2 more
+6 more sources